About me
David Burrow is the Director of the Office of Scientific Investigations (OSI) within the Office of Compliance in the Center for Drug Evaluation and Research (CDER) at the U.S. Food and Drug Administration (FDA). He leads CDER's Bioresearch Monitoring (BIMO) program, overseeing clinical and non-clinical research, human subject protections, clinicaltrials.gov, post-market adverse drug experience reporting, and risk evaluation and mitigation strategies. Mr. Burrow manages the strategic development and implementation of risk-based policy, inspection, and compliance activities to evaluate data integrity in marketing applications, protect the rights and safety of research participants, and ensure compliance with FDA regulations.
